falsefalse

My Treatment Approach: Metastatic Castration-Resistant Prostate Cancer - Episode 10

Closing Thoughts on the Future of mCRPC Treatment

,

Matthew Manning, MD, and Andrew Armstrong, MD, discuss the remaining unmet needs in mCRPC, clinical trials and novel agents to look out for, and share practical advice for other clinicians treating patients with the disease.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: The Evolution of Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    EP. 2: Approved Treatment Options for Patients with mCRPC
    EP. 3: Patient Profile: A 78-Year-Old Man with mCRPC
    EP. 4: Treatment Approaches for Patients with mCRPC and Bone-Only Disease Progression After Radiotherapy
    EP. 5: Patient Profile: A 72-Year-Old Man with mCRPC and Multiple Bone Metastases
    EP. 6: Safety and Efficacy Data on Radium-223 for the Palliative Treatment of mCRPC
    EP. 7: Considerations for Treatment Selection for Patients with Disease Progression on Radium-223
    EP. 8: Patient Profile: A 67-Year-Old Man with mCRPC and Asymptomatic Bone Metastases
    EP. 9: Symptomatic Status and Lesion Size of Bone Metastases: Impact on Radiotherapy Selection in mCRPC
    Now Viewing
    EP. 10: Closing Thoughts on the Future of mCRPC Treatment

    Related Content:

    My Treatment Approach: Metastatic Castration-Resistant Prostate CancerProstate CancerInsights
    Strategic Timing for CAR T in R/R MM: The Importance of Early Referral
    Treatment Strategies to Manage AEs in EGFRm NSCLC
    Guiding Treatment Decisions Post-IO in Advanced EC: Insights from Available Data
    x